; and (2) the extent to which children, adolescents, and young adults are aware of the counterfeit or synthetic nature of any opioids used or encountered by such children, adolescents, and young adults. (b) Reports Not later than 180 days after concluding such evaluation, the Director of the Centers for Disease Control and Prevention shall develop and submit to the Committees on Energy and Commerce and Education and the Workforce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate the findings of the evaluation and, if applicable, recommendations to improve the quality and availability of data described in subsection (a). (c) Authorization of appropriations There is authorized to be appropriated $250,000 for fiscal year 2024 to carry out this section.